Dr Vincent Forster of Versantis, a Swiss biotech aiming to develop a new generation of liver disease therapeutics and diagnostics, introduces the company's foundation story, proprietary technology, and future development goals.
As a start-up company, we try to work in a very lean and dynamic way with a small team that leverages the expertise and support of external partners and advisors, including service providers. This allows us to stay flexible and cost-efficient while accessing the tools and capabilities we need
